Congenital von Willebrand disease type 3: clinical manifestations, pathophysiology and molecular biology

被引:86
作者
Eikenboom, JCJ [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Haematol, Haemostasis & Thrombosis Res Ctr, NL-2300 RC Leiden, Netherlands
关键词
von Willebrand disease; von Willebrand factor; drug therapy; antibodies; factor VIII; congenital; genetics; mutation;
D O I
10.1053/beha.2001.0139
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
von Willebrand disease type 3 is the most severe form of this condition. Patients present with a moderate-to-severe bleeding tendency. The plasma von Willebrand factor level in these patients is very low or undetectable. Although rare, von Willebrand disease type 3 is of major interest because of its severe clinical presentation, the need for replacement therapy and the risk of occurrence of alloantibodies after the infusion of plasma concentrates. The inheritance of type 3 disease is typically autosomal recessive. The parents are often consanguineous, although compound heterozygous inheritance does occur. The molecular basis of von Willebrand disease type 3 has recently been studied in detail, several molecular defects being identified. This chapter will focus on the clinical and molecular aspects of type 3 von Willebrand disease.
引用
收藏
页码:365 / 379
页数:15
相关论文
共 86 条
[31]  
Gazda H, 1997, BLOOD, V90, P3132
[32]  
GINSBURG D, 1993, THROMB HAEMOSTASIS, V69, P177
[33]   CLINICAL AND BIOLOGICAL EVALUATION IN VONWILLEBRANDS DISEASE OF A VONWILLEBRAND-FACTOR CONCENTRATE WITH LOW FACTOR-VIII ACTIVITY [J].
GOUDEMAND, J ;
MAZURIER, C ;
MAREY, A ;
CARON, C ;
COUPEZ, B ;
MIZON, P ;
GOUDEMAND, M .
BRITISH JOURNAL OF HAEMATOLOGY, 1992, 80 (02) :214-221
[34]  
Goudemand J, 1998, HAEMOPHILIA, V4, P48
[35]  
Grossmann RE, 2000, THROMB HAEMOSTASIS, V83, P633
[36]  
Hagiwara T, 1996, THROMB HAEMOSTASIS, V76, P253
[37]   THE INHERITANCE OF TYPE-I AND TYPE-III VONWILLEBRANDS DISEASE IN ISRAEL - LINKAGE ANALYSIS, CARRIER DETECTION AND PRENATAL-DIAGNOSIS USING 3 INTRAGENIC RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISMS [J].
INBAL, A ;
KORNBROT, N ;
ZIVELIN, A ;
SHAKLAI, M ;
SELIGSOHN, U .
BLOOD COAGULATION & FIBRINOLYSIS, 1992, 3 (02) :167-177
[38]   Requirements of von willebrand factor to protect factor VIII from inactivation by activated protein C [J].
Koppelman, SJ ;
vanHoeij, M ;
Vink, T ;
Lankhof, H ;
Schiphorst, ME ;
Damas, C ;
Vlot, AJ ;
Wise, R ;
Bouma, BN ;
Sixma, JJ .
BLOOD, 1996, 87 (06) :2292-2300
[39]  
LOPEZFERNANDEZ MF, 1988, BLOOD, V72, P116
[40]  
Lusher JM, 1998, HAEMOPHILIA, V4, P11